Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
These sleep improvements appeared within the first three weeks of treatment, suggesting BPC-157 may address the sleep disruption cycle common in fibromyalgia
After eating, the gut releases this hormone, essential for controlling blood sugar levels and fostering feelings of fullness
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
Results: Expect reduced pain, increased mobility, and enhanced overall joint function
US$ 27.34
US$ 20.55
US$ 22.55
US$ 24.17
US$ 21.83
US$ 26.53
US$ 25.88
